The Effect of Farlong® NotoGinseng™ (Ginseng Plus®) on Cholesterol and Blood Pressure
Clinical trial NCT04069715 · COMPLETED
Trial details
- NCT number
- NCT04069715
- Sponsor
- LongStar HealthPro, Inc. DBA Farlong Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-20
- Primary completion
- 2019-06-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.